VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA. (Q41630567)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

0 references

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

René G.P.van Gennip

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Femke Feenstra

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Mieke Maris-Veldhuis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Franz J Daus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Mirriam G J Tacken

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Rob J M Moormann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

31 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

7108-7114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454873%20AND%20SRC:MED&resulttype=core&format=json

Experimental reproduction of severe bluetongue in sheep.

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

The pathology and pathogenesis of bluetongue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Detection of Toggenburg Orbivirus by a segment 2-specific quantitative RT-PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Novel bluetongue virus serotype from Kuwait

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

The epidemiology of bluetongue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Bluetongue: history, global epidemiology, and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Culicoides variipennis and bluetongue disease. Research on arthropod-borne animal diseases for control and prevention in the year 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Detection of a fourth orbivirus non-structural protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

In vitro transcription and translation of bluetongue virus mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

A viral nonstructural protein regulates bluetongue virus trafficking and release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Interaction of calpactin light chain (S100A10/p11) and a viral NS protein is essential for intracellular trafficking of nonenveloped bluetongue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Prospects for improved bluetongue vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Vaccines against bluetongue in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Bluetongue virus serotype 6 in Europe in 2008-Emergence and disappearance of an unexpected non-virulent BTV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Persistent infection of BHK21/WI-2 cells with rubella virus and characterization of rubella variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

RNA elements in open reading frames of the bluetongue virus genome are essential for virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Sustained high-throughput polymerase chain reaction diagnostics during the European epidemic of Bluetongue virus serotype 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

T lymphocyte subset alterations following bluetongue virus infection in sheep and cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Protective efficacy of virus-like particles for bluetongue disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Role of neutralising antibody in passive immunity to bluetongue infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Identification of a bluetongue virus serotype 1-specific ovine helper T-cell determinant in outer capsid protein VP2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

The ovine cytotoxic T lymphocyte responses to bluetongue virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

NS3 of bluetongue virus interferes with the induction of type I interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Maximal predicted duration of viremia in bluetongue virus-infected cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Detection of bluetongue virus in the blood of inoculated calves: comparison of virus isolation, PCR assay, and in vitro feeding of Culicoides variipennis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Duration of viraemia infectious to Culicoides sonorensis in bluetongue virus-infected cattle and sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Bluetongue virus with mutated genome segment 10 to differentiate infected from vaccinated animals: a genetic DIVA approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033

inferred from DOI database lookup

7 January 2021

based on heuristic

Recombinant virus vaccine for bluetongue disease in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.033